U.S. flag

An official website of the United States government

NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn) AND Dystonia 12

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Feb 2, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000644928.22

Allele description [Variation Report for NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn)]

NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn)

Gene:
ATP1A3:ATPase Na+/K+ transporting subunit alpha 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn)
Other names:
NM_001256213.1(ATP1A3):c.2434G>A(p.Asp812Asn); NM_001256214.1(ATP1A3):c.2440G>A(p.Asp814Asn); NM_152296.4(ATP1A3):c.2401G>A(p.Asp801Asn)
HGVS:
  • NC_000019.10:g.41970405C>T
  • NG_008015.1:g.28826G>A
  • NM_001256213.2:c.2434G>A
  • NM_001256214.2:c.2440G>A
  • NM_152296.5:c.2401G>AMANE SELECT
  • NP_001243142.1:p.Asp812Asn
  • NP_001243143.1:p.Asp814Asn
  • NP_689509.1:p.Asp801Asn
  • NP_689509.1:p.Asp801Asn
  • LRG_1186t1:c.2401G>A
  • LRG_1186:g.28826G>A
  • LRG_1186p1:p.Asp801Asn
  • NC_000019.9:g.42474557C>T
  • NM_001256214.1:c.2440G>A
  • NM_001256214.2:c.2440G>A
  • NM_152296.3:c.2401G>A
  • NM_152296.4:c.2401G>A
  • P13637:p.Asp801Asn
Protein change:
D801N; ASP801ASN
Links:
UniProtKB: P13637#VAR_068943; OMIM: 182350.0009
Molecular consequence:
  • NM_001256213.2:c.2434G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001256214.2:c.2440G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_152296.5:c.2401G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Dystonia 12 (DYT12)
Synonyms:
DYT-ATP1A3; Rapid-Onset Dystonia-Parkinsonism
Identifiers:
MONDO: MONDO:0007496; MedGen: C1868681; Orphanet: 71517; OMIM: 128235

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000195709GeneReviews
no classification provided
not providedgermlineliterature only

SCV000766650Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 10, 2023)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

SCV001366737Centre for Mendelian Genomics, University Medical Centre Ljubljana
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 30, 2019)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005049674Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 2, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, literature only
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.

Rosewich H, Thiele H, Ohlenbusch A, Maschke U, Altmüller J, Frommolt P, Zirn B, Ebinger F, Siemes H, Nürnberg P, Brockmann K, Gärtner J.

Lancet Neurol. 2012 Sep;11(9):764-73. doi: 10.1016/S1474-4422(12)70182-5. Epub 2012 Jul 30.

PubMed [citation]
PMID:
22850527

Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients.

Ishii A, Saito Y, Mitsui J, Ishiura H, Yoshimura J, Arai H, Yamashita S, Kimura S, Oguni H, Morishita S, Tsuji S, Sasaki M, Hirose S.

PLoS One. 2013;8(2):e56120. doi: 10.1371/journal.pone.0056120. Epub 2013 Feb 8.

PubMed [citation]
PMID:
23409136
PMCID:
PMC3568031
See all PubMed Citations (12)

Details of each submission

From GeneReviews, SCV000195709.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000766650.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 801 of the ATP1A3 protein (p.Asp801Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with alternating hemiplegia of childhood (PMID: 22842232, 22850527, 23409136, 24431296, 24842602). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 37107). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ATP1A3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ATP1A3 function (PMID: 22842232, 24631656, 25523819, 25681536). This variant disrupts the p.D801 amino acid residue in ATP1A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24100174, 26410222). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Centre for Mendelian Genomics, University Medical Centre Ljubljana, SCV001366737.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PM5,PP2,PP3.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV005049674.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024